Content about Diabetes mellitus

PARSIPPANY, N.J. — Generic drug maker Watson is challenging the patent protection on a drug used to treat Type 2 diabetes.

Watson said Thursday that it had filed with the Food and Drug Administration for approval of a generic version of Depomed's Glumetza (metformin hydrochloride extended-release tablets) in the 1,000-mg strength.

Several health-and-wellness programs targeting professional drivers have been gaining traction in the past few months. And for the consumer packaged goods industry, professional drivers represent a crucial cog in the whole supply chain. But it’s a cog that happens to be heavily indexed across many chronic disease states (e.g., obesity, diabetes, heart health) — and for a simple reason. There just aren’t that many healthy choices for those drivers putting the hammer down on the big road.


STOCKHOLM — A group of industrial chemicals commonly found in cosmetics and plastics may disrupt insulin production, particularly among seniors, according to a study published in Diabetes Care.

MINNETONKA, Minn. — A Supervalu banner announced that it will offer patients access to a program created by UnitedHealth Group's Diabetes Prevention and Control Alliance.

PRINCETON, N.J. — The Food and Drug Administration has approved a change to the label of a Novo Nordisk drug stating that it offers superior blood-sugar control to a competing drug made by Merck, based on results of two clinical studies, Novo Nordisk said Monday.

WOONSOCKET, R.I. — CVS/pharmacy officially announced on Wednesday the April schedule of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities throughout 2012.

As part of National Minority Health Month, CVS/pharmacy will offer free health screenings at select stores in African-American and Latino communities in Atlanta, Chicago, Dallas-Fort Worth, Detroit, Houston, Los Angeles, Miami, New York, Philadelphia and Washington, D.C.

INDIANAPOLIS — Marsh Supermarkets on Tuesday recognized National Public Health Week with the introduction of a program to help people with diabetes better understand, manage and live with the disease — more than 9% of Indiana residents have been diagnosed with diabetes, the grocer noted.

NEW YORK — A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

Novo Nordisk said Monday the FDA had approved Levemir (insulin detemir [rDNA origin]) for a pregnancy category B classification, meaning that when used by pregnant women, the insulin did not increase the risk of harm to fetuses. The agency's decision was based on results of a clinical trial involving 310 women that compared Levemir to another insulin product.

The insulin is used to treat Type 1 and Type 2 diabetes.

SOUTH SAN FRANCISCO, Calif. — Daiichi Sankyo and NGM Biopharmaceuticals said they signed a research and licensing agreement to develop treatments for Type 1 and Type 2 diabetes. The drugs would work by reviving beta cells, the decline of which contributes to the disease.

NEW YORK — A commonly prescribed diabetes drug also may have the capability of protecting the heart, according to a Swedish study.

MINNETONKA, Minn. — Supervalu banner Shop 'n Save Pharmacy has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance.

WASHINGTON — People with diabetes are at increased risk of hearing loss, which has prompted two groups to encourage those living with the disease to have their hearing checked.

The American Diabetes Association and the Better Hearing Institute are launching the effort as part of the ADA's Diabetes Alert Day, on Tuesday, which also includes an effort to encourage people to check if they are at risk of developing Type 2 diabetes.